3 Jul 2012
Midday Business News for 3 July 2012
A layyer says more rules won't stop money laundering through New Zealand registered firms. GlaxoSmithKline cops a 3 billion US dollar fine and the sharemarket declines.
A layyer says more rules won't stop money laundering through New Zealand registered firms. GlaxoSmithKline cops a 3 billion US dollar fine and the sharemarket declines.